Crossmark

Effectiveness, Tolerability, and Safety of Belimumab in Patients with Refractory SLE: a Review of Observational Clinical-Practice-Based Studies

Crossref DOI link: https://doi.org/10.1007/s12016-018-8675-2

Published Online: 2018-03-06

Published Print: 2018-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Trentin, Francesca

Gatto, Mariele

Zen, Margherita

Maddalena, Larosa

Nalotto, Linda

Saccon, Francesca

Zanatta, Elisabetta

Iaccarino, Luca

Doria, Andrea http://orcid.org/0000-0003-0548-4983
License Information

Text and Data Mining valid from 2018-03-06
More Information

Article History

First Online: 6 March 2018

Change Date: 23 August 2018

Change Type: Erratum

Change Details: The following changes are made for this article: (1.) Maddalena Larosa’s given name and surname were inadvertently interchanged. The authorgroup section is now corrected. (2.) The author(s)’ decision to opt for Open Choice.

Funding

: The Authors declare no funding support for this paper. Andrea Doria: GSK consultant fee less than $10,000.